These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38385211)

  • 21. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
    Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
    Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.
    Kwon RJ; Park EJ; Lee SY; Lee Y; Hwang C; Kim C; Cho YH
    Lipids Health Dis; 2021 Sep; 20(1):104. PubMed ID: 34511128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
    Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
    Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
    Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
    Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
    Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
    World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
    Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
    Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer.
    Kaur A; Elzagheid A; Birkman EM; Avoranta T; Kytölä V; Korkeila E; Syrjänen K; Westermarck J; Sundström J
    Cancer Med; 2015 Dec; 4(12):1798-808. PubMed ID: 26377365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
    Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
    Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis.
    Peng J; Ou Q; Guo J; Pan Z; Zhang R; Wu X; Zhao Y; Deng Y; Li C; Wang F; Li L; Chen G; Lu Z; Ding P; Wan D; Fang Y
    Aging (Albany NY); 2017 Nov; 9(11):2334-2351. PubMed ID: 29135454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis.
    Krieg A; Werner TA; Verde PE; Stoecklein NH; Knoefel WT
    PLoS One; 2013; 8(6):e65338. PubMed ID: 23755220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High MICB expression as a biomarker for good prognosis of colorectal cancer.
    Feng Q; Yu S; Mao Y; Ji M; Wei Y; He G; Chang W; Zhu D; Ren L; Xu J
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1405-1413. PubMed ID: 32306128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircRNA VPRBP inhibits tumorigenicity of cervical cancer via miR-93-5p/FRMD6 axis.
    Shen L; Dang J; Liu S; Xian B; Deng Y; Qu D
    Reprod Sci; 2022 Aug; 29(8):2251-2264. PubMed ID: 35501594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
    Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
    J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
    Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
    Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.